scholarly journals Relationship among MIF, MCP-1, viral loads, and HBs Ag levelsin chronic hepatitis B patients

2015 ◽  
Vol 45 ◽  
pp. 634-637 ◽  
Author(s):  
Hayati GÜNEŞ ◽  
Rafet METE ◽  
Murat AYDIN ◽  
Birol TOPÇU ◽  
Mustafa ORAN ◽  
...  
2006 ◽  
Vol 80 (6) ◽  
pp. 2968-2975 ◽  
Author(s):  
Olivier Lada ◽  
Yves Benhamou ◽  
Thierry Poynard ◽  
Vincent Thibault

ABSTRACT In chronic hepatitis B (CHB), the persistence of hepatitis B surface antigen (HBs Ag) is sometimes associated with antibodies (Ab) to HBs (anti-HBs). To assess the hypothesis of the selection of HBs Ag immune escape variants in CHB patients, the variability of the HBV S gene was determined for patients persistently carrying both HBs Ag and anti-HBs antibodies and patients solely positive for HBs Ag. We selected 14 patients who presented both markers (group I) in several consecutive samples and 12 patients positive for HBs Ag only (group II). The HBs Ag-encoding gene was amplified and cloned, and at least 15 clones per patient were sequenced and analyzed. The number of residue changes within the S protein was 2.7 times more frequent for group I than for group II patients and occurred mostly in the “a” determinant of the major hydrophilic region (MHR), with 9.52 versus 2.43 changes per 100 residues (P = 0.009), respectively. Ten patients (71%) from group I, but only three (25%) from group II, presented at least two residue changes in the MHR. The most frequent changes in group I patients were located at positions s145, s129, s126, s144, and s123, as described for immune escape variants. In CHB patients, the coexistence of HBs Ag and anti-HBs Ab is associated with an increase of “a” determinant variability, suggesting a selection of HBV immune escape mutants during chronic carriage. The consequences of this selection process with regard to vaccine efficacy, diagnosis, and clinical evolution remain partially unknown.


2014 ◽  
Vol 60 (1) ◽  
pp. S294
Author(s):  
J. Liu ◽  
H.-I. Yang ◽  
M.-H. Lee ◽  
R. Batrla-Utermann ◽  
C.-L. Jen ◽  
...  

2009 ◽  
Vol 50 ◽  
pp. S32
Author(s):  
J.-H. Bockmann ◽  
M. Lütgehetmann ◽  
T. Volz ◽  
A. Köpke ◽  
A.W. Lohse ◽  
...  

2009 ◽  
Vol 6 (3) ◽  
pp. 533-541
Author(s):  
Baghdad Science Journal

Two groups of chronic hepatitis B and C virus patients were divided into Pre-treated patients (25 CHB patients with positive HBs Ag for more than 6 months and 40 CHC patients), and post-treated patients [12 CHB patients (4, 6, and 2 were treated with lamivudine, IFN-? and combination of LMV + IFN-? respectively), and 27 patients for CHC (3, 13 and 11 patients were treated with Ribavirin, IFN-? and combination therapy (RBV+ IFN-?) respectively].These patients were followed up for 6 months. By using ELISA technique, levels of IL-6, IL-10, IFN-? and TNF-? were measured in vivo and in vitro (supernatant of PBMCs stimulated with PHA) and compared with healthy control. The mean level of IL-6, IL-10 and TNF-? in CHB patients showed significant differences (P


2008 ◽  
Vol 83 (6) ◽  
pp. 2663-2674 ◽  
Author(s):  
Julien Crettaz ◽  
Itziar Otano ◽  
Laura Ochoa ◽  
Alberto Benito ◽  
Astrid Paneda ◽  
...  

ABSTRACT Chronic hepatitis B is a major cause of liver-related death worldwide. Interleukin-12 (IL-12) induction accompanies viral clearance in chronic hepatitis B virus infection. Here, we tested the therapeutic potential of IL-12 gene therapy in woodchucks chronically infected with woodchuck hepatitis virus (WHV), an infection that closely resembles chronic hepatitis B. The woodchucks were treated by intrahepatic injection of a helper-dependent adenoviral vector encoding IL-12 under the control of a liver-specific RU486-responsive promoter. All woodchucks with viral loads below 1010 viral genomes (vg)/ml showed a marked and sustained reduction of viremia that was accompanied by a reduction in hepatic WHV DNA, a loss of e antigen and surface antigen, and improved liver histology. In contrast, none of the woodchucks with higher viremia levels responded to therapy. The antiviral effect was associated with the induction of T-cell immunity against viral antigens and a reduction of hepatic expression of Foxp3 in the responsive animals. Studies were performed in vitro to elucidate the resistance to therapy in highly viremic woodchucks. These studies showed that lymphocytes from healthy woodchucks or from animals with low viremia levels produced gamma interferon (IFN-γ) upon IL-12 stimulation, while lymphocytes from woodchucks with high viremia failed to upregulate IFN-γ in response to IL-12. In conclusion, IL-12-based gene therapy is an efficient approach to treat chronic hepadnavirus infection in woodchucks with viral loads below 1010 vg/ml. Interestingly, this therapy is able to break immunological tolerance to viral antigens in chronic WHV carriers.


2011 ◽  
Vol 54 ◽  
pp. S291
Author(s):  
J.M. Kittner ◽  
M.F. Sprinzl ◽  
A. Grambihler ◽  
A. Weinmann ◽  
R.R. Galle ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document